Medscape is available in 5 Language Editions – Choose your Edition here.


Neural Tube Defects Clinical Presentation

  • Author: George I Jallo, MD; Chief Editor: Amy Kao, MD  more...
Updated: Dec 14, 2015


Most open NTDs are readily apparent at the time of birth.

Closed NTDs have a variable presentation.

The most common presentation of a closed NTD is an obvious abnormality along the spine such as a fluid-filled cystic mass, area of hypopigmentation or hyperpigmentation, cutis aplasia, congenital dermal sinus, capillary telangiectasia/hemangioma, hairy patch (hypertrichosis), skin appendages, or asymmetrical gluteal cleft.[13]  Common to all these patients is a fully epithelialized lesion and no visible neural tissue.

A closed NTD can present without a cutaneous marker.

The second most common reason for seeking medical attention is asymmetry of the legs and/or feet. One calf can be thinner, with a smaller foot on the same side, higher arch, and hammering or clawing of the toes.

Other children exhibit progressive spinal deformities such as scoliosis.

Some children present with a picture of progressive neurological deficits that may include weakness in one distal lower extremity, sensory loss in the same distribution, and bladder or bowel dysfunction.

Low back pain also can occur, sometimes without neurological deficit. Pain is more common in older children or adolescents.

Adults can present with the sudden onset of pain, motor and sensory loss, and bladder dysfunction after an acute trauma (eg, fall, motor vehicle accident, placement in lithotomy position). The reason for such presentation may be related to tethering of the cord (the distal end of the spinal cord is fixed in position).[14] Mechanical forces associated with motion may produce compression and/or vascular insufficiency.

A patient with a closed NTD such as a congenital dermal sinus with an intraspinal dermoid cyst or a neurenteric cyst can present with symptoms of spinal cord compression due to enlargement of the mass.

A patient with a dermal sinus also can present with bacterial meningitis or spinal abscess.

Neurenteric or dermoid cysts also can present with repeated bouts of aseptic meningitis due to leaking of the contents into the spinal subarachnoid space.



A complete neurological assessment of the newborn with an open NTD should be performed to document the many possible structural and neurological problems. This provides a baseline for future comparison.

Particularly important aspects of the evaluation are measurement of head circumference, assessment of general vigor (especially cry and sucking), upper extremity motor function, anal sphincter, and urinary stream, as well as thorough motor and sensory examination of the lower extremities and trunk.

Usually the level of sensory dysfunction is slightly greater than the dysfunction detected on the motor examination.

Motor examination involves observation of muscle bulk, spontaneous active movements, movements in response to stimulation, as well as assessment of muscle tone by palpation.

Further information regarding the level of neurological dysfunction can be obtained from evaluation of hip and foot deformities. If the disparity in segmental level between the 2 sides is more than 1 level, an occult neurological problem must be suspected (eg, hemimyelia).

The spine should be examined carefully, with determination of the size and site of the lesion. The shape of the defect, size of the placode, and health and laxity of the surrounding skin and soft tissue should be noted carefully. The presence of early spinal deformity (eg, kyphosis) also should be assessed.



Several genetic and environmental factors have been implicated in the pathogenesis of NTDs.[2] A slight female predominance, and the higher incidence in certain ethnic groups and in the offspring of consanguineous marriages, have suggested a genetic basis for NTDs. Chromosomal abnormalities (trisomy 13, 18, 21) also have been associated with NTDs. Concordance between monozygotic twins is low. Thus, genetic abnormalities are more likely to predispose to environmental factors.

Possible environmental factors include geographic location, season of conception, socioeconomic class, maternal diabetes, maternal age, zinc and folate deficiencies,[15, 16] maternal alcohol abuse, maternal use of valproate, and intrauterine hyperthermia.

Marked seasonal trends in the birth incidence of NTDs have been reported. Anencephaly and spina bifida tend to occur more frequently in spring conceptions (anencephaly peaking in early spring and spina bifida in late spring). This is especially true in areas where the risk is high; however, most US studies failed to demonstrate such variations.

Since encephaloceles do not exhibit geographic, gender, or ethnic variations, some have proposed that they occur after the completion of neurulation.

A cohort study by Jentink et al suggests that carbamazepine monotherapy in the first trimester produces fetal malformations specific to spina bifida; however, the risk is lower than for valproic acid.[17]

Contributor Information and Disclosures

George I Jallo, MD Professor of Neurosurgery, Pediatrics, and Oncology, Director, Clinical Pediatric Neurosurgery, Department of Neurosurgery, Johns Hopkins University School of Medicine

George I Jallo, MD is a member of the following medical societies: American Association of Neurological Surgeons, American Medical Association, American Society of Pediatric Neurosurgeons

Disclosure: Received grant/research funds from Codman (Johnson & Johnson) for consulting; Received grant/research funds from Medtronic for consulting.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Kenneth J Mack, MD, PhD Senior Associate Consultant, Department of Child and Adolescent Neurology, Mayo Clinic

Kenneth J Mack, MD, PhD is a member of the following medical societies: American Academy of Neurology, Child Neurology Society, Phi Beta Kappa, Society for Neuroscience

Disclosure: Nothing to disclose.

Chief Editor

Amy Kao, MD Attending Neurologist, Children's National Medical Center

Amy Kao, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, Child Neurology Society

Disclosure: Have stock from Cellectar Biosciences; have stock from Varian medical systems; have stock from Express Scripts.

Additional Contributors

Robert Stanley Rust, Jr, MD, MA Thomas E Worrell Jr Professor of Epileptology and Neurology, Co-Director of FE Dreifuss Child Neurology and Epilepsy Clinics, Director, Child Neurology, University of Virginia School of Medicine; Chair-Elect, Child Neurology Section, American Academy of Neurology

Robert Stanley Rust, Jr, MD, MA is a member of the following medical societies: Child Neurology Society, Society for Pediatric Research, American Headache Society, International Child Neurology Association, American Academy of Neurology, American Epilepsy Society, American Neurological Association

Disclosure: Nothing to disclose.


The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous coauthor Tibor Becske, MD, to the writing and development of this article.

  1. Dias MS, Li V. Pediatric neurosurgical disease. Pediatr Clin North Am. 1998 Dec. 45(6):1539-78, x. [Medline].

  2. Dirks PB, Rutka JT. The neurogenetic basis of pediatric neurosurgical conditions. In: Albright L, Pollack I, Adelson D, eds. Principles and Practice of Neurosurgery. New York: Thieme Medical Publishers; 1999:. 23-4.

  3. Harris LW, Oakes WJ. Open neural tube defects. In: Tindall GT,Cooper PR, Barrow DL, eds. The Practice of Neurosurgery. Baltimore: Williams & Wilkins; 1996:. 2779-89.

  4. McComb JG, Chen TC. Closed spinal neural tube defects. In: Tindall GT,Cooper PR, Barrow DL, eds. The Practice of Neurosurgery. Baltimore: Williams & Wilkins; 1996:. 2754-77.

  5. McComb JG. Spinal and cranial neural tube defects. Semin Pediatr Neurol. 1997 Sep. 4(3):156-66. [Medline].

  6. O'Rahilly R, Muller F. Neurulation in the normal human embryo. Ciba Found Symp. 1994. 181:70-82; discussion 82-9. [Medline].

  7. Marks JD, Khoshnood B. Epidemiology of common neurosurgical diseases in the neonate. Neurosurg Clin N Am. 1998 Jan. 9(1):63-72. [Medline].

  8. Khoshnood B, Loane M, Walle Hd, Arriola L, Addor MC, et al. Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ. 2015 Nov 24. 351:h5949. [Medline].

  9. Saxena AK, Pandey S, Pandey LK. Genetic diversity of stem cells and their functional impact on the development of neural tube defects in Eastern population of India. Genet Mol Res. 2013 Jul 15. 12(3):2380-90. [Medline].

  10. Schuler-Faccini L, Sanseverino MT, de Rocha Azevedo LM, Moorthie S, Alberg C, Chowdhury S, et al. Health needs assessment for congenital anomalies in middle-income countries: Examining the case for neural tube defects in Brazil. J Community Genet. 2013 Aug 30. [Medline].

  11. Walters J, Ashwal S, Masek T. Anencephaly: where do we now stand?. Semin Neurol. 1997. 17(3):249-55. [Medline].

  12. Mattsson S, Gladh G. [Children with meningomyelocele become adults!]. Lakartidningen. 2005 Sep 12-18. 102(37):2566-70. [Medline].

  13. Drolet B. Birthmarks to worry about. Cutaneous markers of dysraphism. Dermatol Clin. 1998 Jul. 16(3):447-53. [Medline].

  14. George TM, Fagan LH. Adult tethered cord syndrome in patients with postrepair myelomeningocele: an evidence-based outcome study. J Neurosurg. 2005 Mar. 102(2 Suppl):150-6. [Medline].

  15. Barber RC, Lammer EJ, Shaw GM, et al. The role of folate transport and metabolism in neural tube defect risk. Mol Genet Metab. 1999 Jan. 66(1):1-9. [Medline].

  16. MMWR. Use of dietary supplements containing folic acid among women of childbearing age--United States, 2005. MMWR Morb Mortal Wkly Rep. 2005 Sep 30. 54(38):955-8. [Medline].

  17. Jentink J, Dolk H, Loane MA, et al. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ. 2010 Dec 2. 341:c6581. [Medline]. [Full Text].

  18. McLone DG. Care of the neonate with a myelomeningocele. Neurosurg Clin N Am. 1998 Jan. 9(1):111-20. [Medline].

  19. Tubbs RS, Wellons JC, Blount JP, et al. Transient ventriculoperitoneal shunt dysfunction in children with myelodysplasia and urinary bladder infection. Report of three cases. J Neurosurg. 2005 Mar. 102(2 Suppl):221-3. [Medline].

  20. Deacon S. Maternal smoking during pregnancy is associated with a higher risk of non-syndromic orofacial clefts in infants. Evid Based Dent. 2005. 6(2):43-4. [Medline].

  21. Tsurubuchi T, Ichi S, Shim KW, Norkett W, Allender E, Mania-Farnell B, et al. Amniotic fluid and serum biomarkers from women with neural tube defect-affected pregnancies: a case study for myelomeningocele and anencephaly. J Neurosurg Pediatr. 2013 Aug 23. [Medline].

  22. Copp AJ. Prevention of neural tube defects: vitamins, enzymes and genes. Curr Opin Neurol. 1998 Apr. 11(2):97-102. [Medline].

  23. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992 Dec 24. 327(26):1832-5. [Medline].

  24. Mills JL, Scott JM, Kirke PN, et al. Homocysteine and neural tube defects. J Nutr. 1996 Mar. 126(3):756S-760S. [Medline].

Myelomeningocele in a newborn.
Myelomeningocele in a newborn - Lateral view.
Child with Chiari malformation, in whom the tonsils have descended to the level of C2.
MRI of a cervical syrinx in the sagittal plane.
MRI of a cervical syrinx in the axial plane.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.